$VNDA
Vanda Pharmaceuticals Inc.

2014 Q3 Form 10-Q Financial Statement

#000119312514301702 Filed on August 08, 2014

View on sec.gov

Income Statement

Concept 2014 Q3 2014 Q2 2013 Q2
Revenue $14.78M $10.86M $8.319M
YoY Change 69.73% 30.57% -0.7%
Cost Of Revenue $703.0K $198.0K $0.00
YoY Change
Gross Profit $14.08M $10.66M $8.320M
YoY Change 28.17%
Gross Profit Margin 95.24% 98.18% 100.01%
Selling, General & Admin $11.29M $28.14M $5.260M
YoY Change 96.66% 434.96% 46.11%
% of Gross Profit 80.19% 263.87% 63.22%
Research & Development $3.701M $3.514M $6.100M
YoY Change -53.86% -42.39% -51.16%
% of Gross Profit 26.29% 32.95% 73.32%
Depreciation & Amortization $600.0K $800.0K $400.0K
YoY Change 20.0% 100.0% 0.0%
% of Gross Profit 4.26% 7.5% 4.81%
Operating Expenses $14.99M $31.65M $11.36M
YoY Change 8.92% 178.64% -9.05%
Operating Profit -$1.448M -$21.61M -$3.413M
YoY Change -73.34% 533.05% -57.79%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $20.00K $30.00K $30.00K
YoY Change -33.33% 0.0% -62.5%
Pretax Income -$1.430M -$21.58M -$3.383M
YoY Change -73.42% 537.75% -57.75%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$1.426M -$21.58M -$3.383M
YoY Change -73.62% 537.75% -57.75%
Net Earnings / Revenue -9.65% -198.63% -40.67%
Basic Earnings Per Share -$0.04 -$0.64 -$0.11
Diluted Earnings Per Share -$0.04 -$0.64 -$0.11
COMMON SHARES
Basic Shares Outstanding 33.88M shares 33.87M shares 28.38M shares
Diluted Shares Outstanding 28.38M shares

Balance Sheet

Concept 2014 Q3 2014 Q2 2013 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $56.09M $63.59M $103.6M
YoY Change -60.56% -38.62% -28.4%
Cash & Equivalents $15.31M $16.99M $103.6M
Short-Term Investments $40.78M $46.59M $0.00
Other Short-Term Assets $182.0K $234.0K $3.100M
YoY Change -93.72% -92.45% -8.82%
Inventory $1.268M $1.093M $28.00K
Prepaid Expenses
Receivables $3.696M $2.376M $1.641M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $64.84M $71.22M $108.4M
YoY Change -55.91% -34.27% -27.76%
LONG-TERM ASSETS
Property, Plant & Equipment $2.233M $2.312M $2.208M
YoY Change 6.03% 4.71% -11.68%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $800.0K $800.0K $600.0K
YoY Change 60.0% 33.33% -40.0%
Total Long-Term Assets $14.34M $14.95M $8.599M
YoY Change 78.77% 73.88% -20.38%
TOTAL ASSETS
Total Short-Term Assets $64.84M $71.22M $108.4M
Total Long-Term Assets $14.34M $14.95M $8.599M
Total Assets $79.18M $86.17M $117.0M
YoY Change -48.95% -26.32% -27.27%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $547.0K $248.0K $1.167M
YoY Change 48.24% -78.75% -31.35%
Accrued Expenses $6.825M $6.753M $3.770M
YoY Change 50.6% 79.12% -36.1%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $38.85M $38.29M $31.94M
YoY Change 21.75% 19.91% -7.17%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $113.0K $140.0K $80.00M
YoY Change -99.85% -99.83% -24.81%
Total Long-Term Liabilities $113.0K $140.0K $80.00M
YoY Change -99.85% -99.83% -24.81%
TOTAL LIABILITIES
Total Short-Term Liabilities $38.85M $38.29M $31.94M
Total Long-Term Liabilities $113.0K $140.0K $80.00M
Total Liabilities $78.11M $85.29M $111.9M
YoY Change -25.67% -23.8% -20.51%
SHAREHOLDERS EQUITY
Retained Earnings -$357.7M -$356.3M -$298.4M
YoY Change 17.77% 19.41%
Common Stock $358.8M $357.2M $303.4M
YoY Change 1.42% 17.72%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.063M $885.0K $5.026M
YoY Change
Total Liabilities & Shareholders Equity $79.18M $86.17M $117.0M
YoY Change -48.95% -26.32% -27.27%

Cashflow Statement

Concept 2014 Q3 2014 Q2 2013 Q2
OPERATING ACTIVITIES
Net Income -$1.426M -$21.58M -$3.383M
YoY Change -73.62% 537.75% -57.75%
Depreciation, Depletion And Amortization $600.0K $800.0K $400.0K
YoY Change 20.0% 100.0% 0.0%
Cash From Operating Activities -$7.600M -$36.70M -$8.100M
YoY Change -25.49% 353.09% -33.61%
INVESTING ACTIVITIES
Capital Expenditures $0.00 -$300.0K -$100.0K
YoY Change 200.0% -50.0%
Acquisitions
YoY Change
Other Investing Activities $5.800M $10.60M $1.000M
YoY Change 960.0% -176.92%
Cash From Investing Activities $5.700M $10.40M $900.0K
YoY Change 1055.56% -160.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 200.0K 0.000 800.0K
YoY Change -99.59% -100.0%
NET CHANGE
Cash From Operating Activities -7.600M -36.70M -8.100M
Cash From Investing Activities 5.700M 10.40M 900.0K
Cash From Financing Activities 200.0K 0.000 800.0K
Net Change In Cash -1.700M -26.30M -6.400M
YoY Change -104.4% 310.94% -53.28%
FREE CASH FLOW
Cash From Operating Activities -$7.600M -$36.70M -$8.100M
Capital Expenditures $0.00 -$300.0K -$100.0K
Free Cash Flow -$7.600M -$36.40M -$8.000M
YoY Change -25.49% 355.0% -33.33%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2014Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
33877841 shares
CY2014Q1 vnda Operating Lease Commitment Annual Rent
OperatingLeaseCommitmentAnnualRent
400000
CY2013Q2 us-gaap Deferred Revenue
DeferredRevenue
103780000
CY2013Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
103633000
CY2014Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
33877841 shares
CY2014Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
33877841 shares
CY2014Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2014Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2014Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2014Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2014Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2014Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2014Q2 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
587000
CY2014Q2 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
44000000
CY2014Q2 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
234000
CY2014Q2 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2014Q2 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
8700000
CY2014Q2 us-gaap Liabilities Current
LiabilitiesCurrent
38294000
CY2014Q2 us-gaap Common Stock Value
CommonStockValue
34000
CY2014Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2014Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
248000
CY2014Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-356278000
CY2014Q2 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
1538000
CY2014Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
357119000
CY2014Q2 us-gaap Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
10000
CY2014Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6753000
CY2014Q2 us-gaap Stockholders Equity
StockholdersEquity
885000
CY2014Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
140000
CY2014Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
945000
CY2014Q2 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
15238000
CY2014Q2 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
1576000
CY2014Q2 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
1500000
CY2014Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
86172000
CY2014Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
2708000
CY2014Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
31059000
CY2014Q2 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
1337000
CY2014Q2 us-gaap Liabilities
Liabilities
85287000
CY2014Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1255000
CY2014Q2 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
2853000
CY2014Q2 us-gaap Deferred Revenue
DeferredRevenue
75059000
CY2014Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
16994000
CY2014Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
411000
CY2014Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2312000
CY2014Q2 us-gaap Available For Sale Securities
AvailableForSaleSecurities
46591000
CY2014Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4166000
CY2014Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
785000
CY2014Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
11855000
CY2014Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
411000
CY2014Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
941000
CY2014Q2 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
5818000
CY2014Q2 us-gaap Assets
Assets
86172000
CY2014Q2 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
46591000
CY2014Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
2144000
CY2014Q2 us-gaap Inventory Net
InventoryNet
1093000
CY2014Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
145000
CY2014Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2376000
CY2014Q2 us-gaap Other Assets Current
OtherAssetsCurrent
234000
CY2014Q2 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
2616000
CY2014Q2 us-gaap Prepaid Insurance
PrepaidInsurance
708000
CY2014Q2 us-gaap Supplies
Supplies
608000
CY2014Q2 us-gaap Assets Current
AssetsCurrent
71220000
CY2014Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
1071000
CY2014Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
2000000
CY2014Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
7000
CY2014Q2 vnda Number Of Stock Incentive Plans
NumberOfStockIncentivePlans
2 EquityPlan
CY2014Q2 vnda Liabilities Recorded Contractual Obligations Relating To License Agreements
LiabilitiesRecordedContractualObligationsRelatingToLicenseAgreements
0
CY2014Q2 vnda Accrued Research And Development Expense
AccruedResearchAndDevelopmentExpense
1845000
CY2014Q2 vnda Liabilities Recorded Future License Payments
LiabilitiesRecordedFutureLicensePayments
0
CY2012Q4 us-gaap Deferred Revenue
DeferredRevenue
117064000
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
88772000
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
33338543 shares
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
33338543 shares
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2013Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2013Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2013Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2013Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2013Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
63486000
CY2013Q4 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
221000
CY2013Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
32851000
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
33000
CY2013Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2013Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
661000
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-308170000
CY2013Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
352240000
CY2013Q4 us-gaap Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
21000
CY2013Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5180000
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
44124000
CY2013Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
665000
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
143349000
CY2013Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
2015000
CY2013Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
26789000
CY2013Q4 us-gaap Liabilities
Liabilities
99225000
CY2013Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
176000
CY2013Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
2888000
CY2013Q4 us-gaap Deferred Revenue
DeferredRevenue
90275000
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
64764000
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2198000
CY2013Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
530000
CY2013Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
65586000
CY2013Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2703000
CY2013Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
500000
CY2013Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
5037000
CY2013Q4 us-gaap Assets
Assets
143349000
CY2013Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
65586000
CY2013Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2031000
CY2013Q4 us-gaap Other Assets Current
OtherAssetsCurrent
128000
CY2013Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
2408000
CY2013Q4 us-gaap Prepaid Insurance
PrepaidInsurance
167000
CY2013Q4 us-gaap Assets Current
AssetsCurrent
135614000
CY2013Q4 vnda Accrued Research And Development Expense
AccruedResearchAndDevelopmentExpense
2324000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
0.62 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.46
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-17168000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00 pure
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y11D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0116 pure
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
28361340 shares
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.28
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4997542 shares
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-10000
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
-10000
us-gaap Licenses Revenue
LicensesRevenue
13284000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1316000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-7902000
us-gaap Other Income
OtherIncome
76000
us-gaap Operating Income Loss
OperatingIncomeLoss
-7978000
us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
-121000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-7912000
us-gaap Royalty Revenue
RoyaltyRevenue
3103000
us-gaap Revenues
Revenues
16387000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
72000
us-gaap Net Income Loss
NetIncomeLoss
-7902000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
473000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
196000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2411000
us-gaap Deferred Revenue Revenue Recognized
DeferredRevenueRevenueRecognized
13284000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
212000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-13284000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
14211000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
9413000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
741000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
14861000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
us-gaap Employee Service Share Based Compensation Cash Received From Exercise Of Stock Options
EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions
797000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
601000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1417000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
31428000
us-gaap Advertising Expense
AdvertisingExpense
0
us-gaap Costs And Expenses
CostsAndExpenses
24365000
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
500000
us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
880000
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
31500000
us-gaap Share Based Compensation
ShareBasedCompensation
2432000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
206000
us-gaap Shares Paid For Tax Withholding For Share Based Compensation
SharesPaidForTaxWithholdingForShareBasedCompensation
32386 shares
dei Document Type
DocumentType
10-Q
dei Entity Registrant Name
EntityRegistrantName
Vanda Pharmaceuticals Inc.
dei Trading Symbol
TradingSymbol
VNDA
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
0.64 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
7.14
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-60569000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00 pure
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y9M29D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0177 pure
us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"> <b><i>Use of estimates</i></b></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"> The preparation of financial statements in conformity with GAAP requires management to make estimates that affect the reported amounts of assets and liabilities at the date of the financial statements, disclosure of contingent assets and liabilities, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> </div>
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
33777207 shares
dei Document Period End Date
DocumentPeriodEndDate
2014-06-30
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P4Y
dei Entity Central Index Key
EntityCentralIndexKey
0001347178
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.42
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3805191 shares
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
20544000
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
-245000
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
2480000
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
1559000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-11000
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
-11000
us-gaap Licenses Revenue
LicensesRevenue
15216000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1463000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1093000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-48108000
us-gaap Other Income
OtherIncome
76000
us-gaap Operating Income Loss
OperatingIncomeLoss
-48184000
us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
-96000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-48119000
us-gaap Royalty Revenue
RoyaltyRevenue
3230000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
8000000
us-gaap Revenues
Revenues
20005000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
378000
us-gaap Net Income Loss
NetIncomeLoss
-48108000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
345000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2836000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
436000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2761000
us-gaap Deferred Revenue Revenue Recognized
DeferredRevenueRevenueRecognized
15216000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
264000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-15216000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10777000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
56032000
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
436000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1573000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
10756000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
1400000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1182000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-47770000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
us-gaap Cost Of Goods Sold
CostOfGoodsSold
198000
us-gaap Employee Service Share Based Compensation Cash Received From Exercise Of Stock Options
EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions
2479000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
2043000
us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
20000
us-gaap Advertising Expense
AdvertisingExpense
4300000
us-gaap Costs And Expenses
CostsAndExpenses
68189000
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
800000
us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-413000
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
31235000
us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
8198000
us-gaap Share Based Compensation
ShareBasedCompensation
2836000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
118000
vnda Share Based Compensation Option Awards Contractual Term
ShareBasedCompensationOptionAwardsContractualTerm
P10Y
vnda Share Based Compensation Arrangement By Share Based Payment Award Remaining Percentage Of Share Subject To Option Awards
ShareBasedCompensationArrangementByShareBasedPaymentAwardRemainingPercentageOfShareSubjectToOptionAwards
0.75 pure
vnda Percentage Of Responsibility For Patients Cost Of Branded Prescription
PercentageOfResponsibilityForPatientsCostOfBrandedPrescription
0.50 pure
vnda Initial Stock Options Granted To Directors Vesting And Exercisable Period
InitialStockOptionsGrantedToDirectorsVestingAndExercisablePeriod
P4Y
vnda Option Awards Vesting Period After Completion Of One Year Of Service
OptionAwardsVestingPeriodAfterCompletionOfOneYearOfService
P3Y
vnda Sharebased Compensation Arrangement By Sharebased Payment Award Restricted Stock Units Or Non Vested Shares Vesting Period1
SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockUnitsOrNonVestedSharesVestingPeriod1
P4Y
vnda Share Based Compensation Arrangement By Share Based Payment Award Percentage Of Share Subject To Option Awards
ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfShareSubjectToOptionAwards
0.25 pure
vnda Subsequent Stock Options Granted To Directors Vesting And Exercisable Period
SubsequentStockOptionsGrantedToDirectorsVestingAndExercisablePeriod
P1Y
CY2004Q1 vnda Percentage Of Future Sublicense Fees Payable
PercentageOfFutureSublicenseFeesPayable
Mid-twenties
CY2013Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
28377254 shares
CY2013Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.12
CY2013Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4234017 shares
CY2013Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
CY2013Q2 us-gaap Licenses Revenue
LicensesRevenue
6678000
CY2013Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3383000
CY2013Q2 us-gaap Other Income
OtherIncome
30000
CY2013Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-3413000
CY2013Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3383000
CY2013Q2 us-gaap Royalty Revenue
RoyaltyRevenue
1641000
CY2013Q2 us-gaap Revenues
Revenues
8319000
CY2013Q2 us-gaap Net Income Loss
NetIncomeLoss
-3383000
CY2013Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1107000
CY2013Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6100000
CY2013Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5260000
CY2013Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
372000
CY2013Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
CY2013Q2 us-gaap Costs And Expenses
CostsAndExpenses
11732000
CY2013Q2 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
300000
CY2013Q2 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
CY2014Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
33874625 shares
CY2014Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.64
CY2014Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3739874 shares
CY2014Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
1559000
CY2014Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
2000
CY2014Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
2000
CY2014Q2 us-gaap Licenses Revenue
LicensesRevenue
7764000
CY2014Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-21575000
CY2014Q2 us-gaap Other Income
OtherIncome
31000
CY2014Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-21606000
CY2014Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-21573000
CY2014Q2 us-gaap Royalty Revenue
RoyaltyRevenue
1539000
CY2014Q2 us-gaap Revenues
Revenues
10862000
CY2014Q2 us-gaap Net Income Loss
NetIncomeLoss
-21575000
CY2014Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1407000
CY2014Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3514000
CY2014Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
28139000
CY2014Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
617000
CY2014Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
CY2014Q2 us-gaap Cost Of Goods Sold
CostOfGoodsSold
198000
CY2014Q2 us-gaap Advertising Expense
AdvertisingExpense
3300000
CY2014Q2 us-gaap Costs And Expenses
CostsAndExpenses
32468000
CY2014Q2 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
400000
CY2014Q2 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax

Files In Submission

Name View Source Status
0001193125-14-301702-index-headers.html Edgar Link pending
0001193125-14-301702-index.html Edgar Link pending
0001193125-14-301702.txt Edgar Link pending
0001193125-14-301702-xbrl.zip Edgar Link pending
d736209d10q.htm Edgar Link pending
d736209dex311.htm Edgar Link pending
d736209dex312.htm Edgar Link pending
d736209dex321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
vnda-20140630.xml Edgar Link completed
vnda-20140630.xsd Edgar Link pending
vnda-20140630_cal.xml Edgar Link unprocessable
vnda-20140630_def.xml Edgar Link unprocessable
vnda-20140630_lab.xml Edgar Link unprocessable
vnda-20140630_pre.xml Edgar Link unprocessable